Sort   by:  
 Page size 
UnknownCXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients.
Not available
S-EPMC9655815 | biostudies-literature
UnknownRandomized, Noncomparative, Phase II Trial of Early Switch From Docetaxel to Cabazitaxel or Vice Versa, With Integrated Biomarker Analysis, in Men With Chemotherapy-Naive, Metastatic, Castration-Resistant Prostate Cancer.
Not available
S-EPMC5791829 | biostudies-literature
UnknownEvaluation of the diagnostic accuracy of a new point-of-care rapid test for SARS-CoV-2 virus detection.
Not available
S-EPMC7752099 | biostudies-literature
UnknownThe CXCR4 antagonist R54 targets epithelial-mesenchymal transition (EMT) in human ovarian cancer cells.
Not available
S-EPMC11658595 | biostudies-literature
UnknownBNT162b2 Elicited an Efficient Cell-Mediated Response against SARS-CoV-2 in Kidney Transplant Recipients and Common Variable Immunodeficiency Patients.
Not available
S-EPMC10459971 | biostudies-literature
UnknownHepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment.
Not available
S-EPMC11014815 | biostudies-literature
UnknownAflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol.
Not available
S-EPMC8010802 | biostudies-literature
UnknownKIR2DL2/DL3+NKs and Helios+Tregs in Peripheral Blood Predict Nivolumab Response in Patients with Metastatic Renal Cell Cancer.
Not available
S-EPMC11474171 | biostudies-literature
UnknownBiological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients.
Not available
S-EPMC8997727 | biostudies-literature
UnknownCetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol.
Not available
S-EPMC6734266 | biostudies-literature
Sort   by:  
 Page size